SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Pfenex focuses on biosimilars post IPO

Pfenex set for new direction as it uses its expression technology to develop its biosimilar pipeline

Revenues from protein production will decline as Pfenex shifts attention to its biosimilar pipeline, the newly public company says.

Related news

News in brief

A German biobank has made stem cells available to API firms this week in a bid to support industry drug development efforts.

ZMapp, the experimental Ebola therapy given to a handful of infected patients in West Africa, is being produced in tobacco plants for Mapp Biopharmaceutical by CMO Kentucky Bioprocessing in collaboration with drugmaker Defyrus.

Minomic International has teamed up with Catalent to develop an antibody-drug conjugate (ADC) to target prostate cancer.

Novo Nordisk has bought a biomanufacturing facility earmarked for closure by Olympus Biotech and begun rehiring staff in order to support its haemophilia product pipeline.

Acquisitions in the single-use tech space helped drive growth in fiscal 2014 according to Pall, which plans to continue its two-pronged M&A strategy.

Global Industry News

Baxter donates IVs to aid groups fighting Ebola in Africa from in-PharmaTechnologist.com

Baxter International has donated intravenous fluids to aid organisations treating Ebola infected patients in Liberia and Sierra Leone.

Standardising trial measurements could stop ‘wasteful’ research from Outsourcing-Pharma.com

Regulators are showing interest in a database of clinical trial endpoints to cut redundant research, although contract research organisation Parexel has expressed reservations.

INFOGRAPHIC

Is Pfizer now eyeing up Actavis three months after failed AZ bid? from in-PharmaTechnologist.com

Pfizer is rumoured to be eyeing up Actavis three months after failing to woo AstraZeneca in a $120bn megamerger, but what would such a deal bring to the Pharma Giant? In-Pharmatechnologist investigates.

If it’s an IATA certified cold chain, this must be Belgium from Outsourcing-Pharma.com

Brussels airport has become the first European shipping hub to adopt a cold-chain certification programme for pharmaceutical cargo that industry group IATA claims “goes beyond” GDP requirements.

GSK: GM yeast breakthrough won't kill off poppy-based opium from in-PharmaTechnologist.com

Poppies will continue to be the main source of industrial opiates long-term according to GSK, despite a recent breakthrough in efforts to produce it in GM yeast.

US claims Dr Reddy’s broke safety packaging rules for 4 years from in-PharmaTechnologist.com

Dr Reddy’s Laboratories says accusations by the US Government’s Consumer Product Safety Commission (CPSC) that it violated childproof packaging rules could cause significant losses for the company.

Spotlight

GSK and Immunovaccine: delivery techs promise to deliver Ebola vax

GSK and Immunovaccine: delivery techs promise to deliver Ebola vaccine

A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a...

2020 vision: A look at the future of the biosimilars market
Feature

2020 vision: A look at the future of the biosimilars market

BioPharma-Reporter.com takes a look at the players, patent expiries and legal wrangles that will dominate the biosimilars...

Reinspection lands Alexion with 483 for Soliris plant

Reinspection lands Alexion with 483 for Soliris plant

A US FDA reinspection of Alexion’s Rhode Island facility hit with a warning letter last year has...

Janssen acquires Fynomer mAb platform in Covagen buy-out

Janssen acquires Fynomer mAb platform in Covagen buy-out

Johnson & Johnson subsidiary Janssen has acquired monoclonal antibody (mAb) platform FynomAb through its purchase of private...

Vast majority of ADC manufacturing outsourced, report finds

Vast majority of ADC manufacturing outsourced, report finds

Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report .